Home 5 Lab Industry Advisor 5 Laboratory Industry Report 5 Deals-lir 5 Industry Buzz: The 10 Biggest DX Mergers of 2019

Industry Buzz: The 10 Biggest DX Mergers of 2019

by | Jan 14, 2020 | Deals-lir, Essential, Industry Buzz-lir, Laboratory Industry Report

Conspicuous by its absence from the list is the proposed $1.2 billion Illumina takeover of Pacific Biosciences which suddenly seems to be in major trouble. Here are the 10-highest value M&A diagnostics deals that did come off in 2019.

Conspicuous by its absence from the list is the proposed $1.2 billion Illumina takeover of Pacific Biosciences which suddenly seems to be in major trouble. Here are the 10-highest value M&A diagnostics deals that did come off in 2019.

 

Top 10 Lab M&A Deals of 2019

Rank Buyer Target Reported Price
1 Danaher GE Biopharma $21.4 billion
2 Exact Sciences Genomic Health $2.8 billion (cash + stock)
3 Thermo Fisher Scientific Brammer Bio $1.7 billion
4 Agilent Technologies BioTek Instruments $1.17 billion
5 PHC Holdings (formerly known as Panasonic Healthcare Holdings) Thermo Fisher Scientific $1.14 billion
6 Sartorius Danaher $750 million*
7 Covance Drug Development (part of LabCorp) Envigo $485 million
8 Beckman Coulter Life Sciences Labcyte $308 million
9 PerkinElmer Cisbio Bioassays $219.8 million
10  Clayton, Dubilier & Rice investment funds Cynosure (owned by Hologic) $205 million

* Announced in 2019 with closing scheduled for 2020

Subscribe to view Essential

Start a Free Trial for immediate access to this article